Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

The Zika virus modifies the chemical composition of human skin, making individuals more attractive to mosquitoes. These ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Nanoneedle technology offers the capability to simultaneously quantify titers of true, full viral genomes and a range of partial species.